Search results
Professor Aimin Xu is currently a Professor in the Department of Medicine, School of Clinical Medicine and also the director for State Key Laboratory of Pharmaceutical Biotechnology (www.sklpb.hku.hk) at the University of Hong Kong.
Aimin Xu is currently a Chair Professor jointly appointed by the Department of Medicine and the Department of Pharmacology & Pharmacy, and also the director for State Key Laboratory of Pharmaceutical Biotechnology (www.sklpb.hku.hk) at the University of Hong Kong.
Professor Aimin Xu and his research associates Research Interests Obesity is a major risk factor of type 2 diabetes (T2DM), insulin resistance and cardiovascular diseases (CVDs).
Our primary research interest is to investigate the role of adipokines in the pathogenesis of obesity-related insulin resistance, systemic inflammation, T2DM and vascular dysfunctions in animal models and human subjects.
Aimin Xu. Department of ... the University of Hong Kong. Verified email at hku.hk. Obesity diabetes biomarker discovery adipocyte biology adipokines. Articles Cited by Public access. Title. Sort. Sort by citations Sort by year Sort by title. Cited by. ... A Xu, WS Chow, MCW Lam, VHG Ai, SCF Tam, KSL Lam. The Journal of Clinical Endocrinology ...
You may log into your ResearcherPage with your HKU Portal, and use the "Manage Publications" entry on the green left side menu, to unlink publications from your ResearcherPage, or, select a few to appear in a new box, "Selected Publications".
Aimin XU | Cited by 36,452 | of The University of Hong Kong, Hong Kong (HKU) | Read 711 publications | Contact Aimin XU
